{{Rsnum
|rsid=4975616
|Chromosome=5
|position=1315545
|Orientation=plus
|GMAF=0.4118
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 35.4 | 45.1 | 19.5
| HCB | 68.6 | 29.2 | 2.2
| JPT | 75.2 | 23.9 | 0.9
| YRI | 4.1 | 31.3 | 64.6
| ASW | 7.0 | 45.6 | 47.4
| CHB | 68.6 | 29.2 | 2.2
| CHD | 68.5 | 28.7 | 2.8
| GIH | 65.3 | 31.7 | 3.0
| LWK | 9.1 | 52.7 | 38.2
| MEX | 53.4 | 44.8 | 1.7
| MKK | 24.4 | 46.8 | 28.8
| TSI | 30.4 | 54.9 | 14.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=19654303
|Title=Deciphering the Impact of Common Genetic Variation on Lung Cancer Risk: A Genome-Wide Association Study
|OA=1
}}

{{PMID Auto
|PMID=19836008
|Title=A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma.
|OA=1
}}

{{PMID Auto
|PMID=19955392
|Title=Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers.
}}

{{PMID Auto
|PMID=20445798
|Title=Chromosome 5p Region SNPs Are Associated with Risk of NSCLC among Women.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs4975616
|overall_frequency_n=72
|overall_frequency_d=126
|overall_frequency=0.571429
|n_genomes=39
|n_genomes_annotated=0
|n_haplomes=57
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}